Serina Therapeutics Inc
Biotechnology
Healthcare
SER
9.76 M shares
NYSE MKT US
traded
23 Sep 2025
listed
no
open
5.20
52 week high
8.63
high
5.29
52 week low
0.00
previous Close
5.09
P/E ratio
market cap
59.21 M
div yield
0
net incoming
-4.81 M
-75.66 %
net profit margin
-481300000.00 %
0.00 %
operating incoming
-5.86 M
-5.57 %
net change in cash
595 K
36.16 %
cash on hand
4.27 M
16.20 %
top